Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
- PMID: 7963543
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
Abstract
These studies have examined the binding of the three IL-1 ligands, IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist (IL-1 ra), to soluble forms of types I and II IL-1Rs (sIL-1RI and sIL-1RII). This interaction was measured in direct binding experiments, in which the ligands bound to immobilized sIL-1R, and in inhibition experiments, in which sIL-1R in solution inhibited the binding of IL-1 ligands to immobilized sIL-1R. In addition, the effects of sIL-1R on the detection of IL-1 ligands by ELISA were examined. Finally, levels of sIL-1R in synovial fluid samples were determined, and their effects on measurement of IL-1 in these samples were estimated. IL-1 beta bound more avidly to sIL-1RII than IL-1 alpha or IL-1ra, primarily because of a slow dissociation rate. In contrast, IL-1 ra bound more avidly than IL-1 alpha or IL-1 beta to sIL-1RI, again because of a slow dissociation rate. sIL-1RII and sIL-1RI inhibited the detection of IL-1 beta and IL-1ra, respectively, by ELISA. Low levels of sIL-1RI (approximately 1.0-2.5 ng/ml) were present in all synovial fluids, irrespective of the degree of inflammation, and were correlated inversely with the levels of measured IL-1ra. In contrast, higher levels of sIL-1RII (approximately 10-20 ng/ml) were found in inflammatory synovial fluids and were not correlated with IL-1ra levels. IL-1 beta could not be detected in any synovial fluid. These results suggest that some IL-1 beta and IL-1ra may be bound in vivo to sIL-1RII and sIL-1RI, respectively, leading to underestimations of cytokine concentrations in body fluids when measured by ELISA.
Similar articles
-
IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.Arch Oral Biol. 2004 Jun;49(6):493-9. doi: 10.1016/j.archoralbio.2003.12.008. Arch Oral Biol. 2004. PMID: 15099807
-
Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.Eur J Immunol. 1995 Oct;25(10):2842-50. doi: 10.1002/eji.1830251020. Eur J Immunol. 1995. PMID: 7589081
-
Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.Arthritis Rheum. 1998 Jun;41(6):1083-9. doi: 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9. Arthritis Rheum. 1998. PMID: 9627018
-
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.Int Rev Immunol. 1998;16(5-6):457-99. doi: 10.3109/08830189809043005. Int Rev Immunol. 1998. PMID: 9646173 Review.
-
Regulation of IL-1 activity by soluble IL-1 receptors.Behring Inst Mitt. 1995 Jun;(96):45-57. Behring Inst Mitt. 1995. PMID: 7575352 Review. No abstract available.
Cited by
-
Diverse Control Mechanisms of the Interleukin-1 Cytokine Family.Front Cell Dev Biol. 2022 Jun 27;10:910983. doi: 10.3389/fcell.2022.910983. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35832789 Free PMC article. Review.
-
Regulation of serum amyloid A protein expression during the acute-phase response.Biochem J. 1998 Sep 15;334 ( Pt 3)(Pt 3):489-503. doi: 10.1042/bj3340489. Biochem J. 1998. PMID: 9729453 Free PMC article. Review.
-
White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.J Exp Orthop. 2016 Dec;3(1):9. doi: 10.1186/s40634-016-0043-7. Epub 2016 Feb 9. J Exp Orthop. 2016. PMID: 26915009 Free PMC article.
-
Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling.Nat Commun. 2017 Oct 9;8(1):810. doi: 10.1038/s41467-017-00864-2. Nat Commun. 2017. PMID: 28993621 Free PMC article.
-
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Front Immunol. 2013 Jul 9;4:181. doi: 10.3389/fimmu.2013.00181. eCollection 2013. Front Immunol. 2013. PMID: 23847622 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources